JBM Healthcare Announces FY2024 Annual Results

JBM Healthcare Announces FY2024 Annual Results

KEY HIGHLIGHTSYear-on-year revenue increased by 24.6%, totalling HK$648.4 millionAdjusted profit attributable to equity shareholders* soared 149.5% to HK$130.5 millionThe Board recommends a final dividend of HK4.05 cents per shareAll three business segments exhibited robust growth momentumFlagship proprietary brands Ho Chai Kung and Po Chai Pills led with impressive growthCross-border e-commerce continued to grow on various platformsHONG KONG…
Read More

Zaļā Josta - Reklāma